Pioneering the discovery of membrane-permeable and orally available cyclic-peptides.

Reversing Type II diabetes with a clinically proven treatment.

Ushering in truly personalized medicine by sequencing a human genome for $100.

Realizing the potential of gene therapy with the world’s first mRNA “programming language.”

Tackling incurable disease with tailored cell therapy solutions.

Revolutionizing medical imaging using new advances in quantum physics.

Transforming drug discovery into measurement-driven drug design.

Harnessing the untapped power of lasso peptides to create an entirely new class of programmable medicines.

Accelerating breakthroughs in neuroscience by imaging neural activity in vivo.

Transforming human antibodies into drugs.

Managing heart disease through a data-driven virtual clinic powered by advanced cardiac monitoring.

AI-driven RNA drug discovery

Take control of your warehouse operations. Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations

Protects applications at runtime with a hardware-grade security perimeter.

Pioneering new gene editing modalities using multi-kilobase RNA editing to treat undruggable diseases.

Making manual labor safe and scalable with legged robots that go where humans go.

Improving drug development through the use of artificial intelligence, computation, and biological automation.

Automating life sciences, so that you can focus on the science, while robots do the work.

Now part of Amazon, Canvas Technology provides unrivaled perception enabling robust autonomy in the most challenging environments.

Making one-hour delivery possible and profitable with an on-demand micro-fulfillment platform.

Providing farmers with sustainable solutions to feed a growing world using AI and automation.

Unlocking subsurface potential of critical minerals using advanced geophysics

Giving remote employees the meeting experience they deserve with IoT video conferencing hardware.

Building humanity’s multiplanetary future.

Powering the future of e-commerce order fulfillment with a solution that can automatically handle any item.

Creating the world’s first industrial-grade cognitive platform for robots.

Building the most advanced flying AI to navigate the world with unparalleled autonomy.

Manufacturing mission critical parts using industrial 3D metal printing. NYSE: VLD

Increasing mobile revenue with enterprise-grade deeplinks across all platforms.

A green materials platform working towards zero-carbon iron and steel and other future-facing metal production.

Decoupling storage and compute for zero-schema log management.

Encouraging safer driver behavior in real-time with in-vehicle AI technology.

Redesigning shipping for the unique challenges of e-commerce.

Sending life-saving data from any connected device to 9-1-1 and first responders.

Reimagining the warehouse for modern e-commerce.

Now part of DC Capital Partners, uAvionix protects the skies one drone at a time with a redefined transponder.

Now part of Discord, Sentropy provides software solutions that protect online communities from hate and harassment using machine learning.

Transforming the way the world interacts with information through its integrated space-based communications and data network.

Using light to move data between chips delivering 1000x the bandwidth at 1/10th the power.

Attacking the physics of memory-compute integration, delivering 10X compute efficiency for the same power envelope.

Now part of Databricks, MosaicML trains and deploys generative AI models with your own data, in your own secure environment.

Now part of Intel, Nervana is building a full-stack solution that is optimized from algorithms down to silicon to solve machine learning problems at scale.

Freeing human knowledge from the boundaries of compute with software defined hardware.

Developing quantum algorithms to accelerate the practical application of quantum computing.

Building the first useful quantum computer.

We partner up with entrepreneurs to build the future.

Let’s Talk.